Wp. Long et al., PROTEIN-KINASE-C ACTIVITY IS REQUIRED FOR ARYL-HYDROCARBON RECEPTOR PATHWAY-MEDIATED SIGNAL-TRANSDUCTION, Molecular pharmacology, 53(4), 1998, pp. 691-700
The role of protein kinase C (PKC) in the human aryl hydrocarbon recep
tor (hAhR) signal transduction pathway was examined in cell lines stab
ly transfected with pGUDLUC6.1, in which luc(+) is solely controlled b
y four dioxin-responsive elements (DREs). These cell lines, P5A11 and
HG40/6, were derived from HeLa and HepG2 cells respectively. Simultane
ous treatment of these cells with 2,3,7,8,-tetrachlorodibenzo-p-dioxin
(TCDD) and phorbol-12-myristate-13-acetate (PMA) enhanced transactiva
tion of the reporter construct several-fold relative to cells treated
with TCDD alone. PKC inhibitors block the PMA effect and hAhR-mediated
signal transduction, demonstrating these processes require PKC activi
ty. Examination of other independently generated, HeLa-derived cell li
nes stably transfected with pGUDLUC6.1 demonstrates the PMA effect in
P5A11 cells is not a clonal artifact. Transient transfections indicate
the PMA effect is not due to a luciferase message/gene product stabil
ization mechanism or stimulation of the basal transcription machinery.
Examination of cytosolic preparations demonstrates PKC stimulation or
inhibition does not alter hAhR and hAhR nuclear translocator protein
levels or TCDD-induced down-regulation of hAhR levels. Similarly, exam
ination of nuclear extracts indicated PKC stimulation or inhibition do
es not alter nuclear AhR levels or hAhR/hAhR nuclear translocator prot
ein heterodimer DRE-binding activity as assessed by electrophoretic mo
bility shift assay. These results demonstrate a PKC-mediated event is
required for the hAhR to form a functional transcriptional complex tha
t leads to trans-activation and that the DRE is the minimal DNA elemen
t required for PMA to enhance AhR-mediated trans-activation.